Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2014 4
2015 1
2016 1
2017 1
2018 2
2019 5
2020 4
2021 6
2022 5
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Neuroprotective effects of G9a inhibition through modulation of peroxisome-proliferator activator receptor gamma-dependent pathways by miR-128.
Bellver-Sanchis A, Ávila-López PA, Tic I, Valle-García D, Ribalta-Vilella M, Labrador L, Banerjee DR, Guerrero A, Casadesus G, Poulard C, Pallàs M, Griñán-Ferré C. Bellver-Sanchis A, et al. Among authors: poulard c. Neural Regen Res. 2024 Nov 1;19(11):2532-2542. doi: 10.4103/1673-5374.393102. Epub 2024 Jan 8. Neural Regen Res. 2024. PMID: 38526289 Free article.
PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer.
Noureddine LM, Ablain J, Surmieliova-Garnès A, Jacquemetton J, Pham TH, Marangoni E, Schnitzler A, Bieche I, Badran B, Trédan O, Hussein N, Le Romancer M, Poulard C. Noureddine LM, et al. Among authors: poulard c. Life Sci Alliance. 2023 Aug 3;6(10):e202302009. doi: 10.26508/lsa.202302009. Print 2023 Oct. Life Sci Alliance. 2023. PMID: 37536978 Free PMC article.
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer.
Poulard C, Ha Pham T, Drouet Y, Jacquemetton J, Surmielova A, Kassem L, Mery B, Lasset C, Reboulet J, Treilleux I, Marangoni E, Trédan O, Le Romancer M. Poulard C, et al. EMBO Mol Med. 2023 Aug 7;15(8):e17248. doi: 10.15252/emmm.202217248. Epub 2023 Jul 17. EMBO Mol Med. 2023. PMID: 37458145 Free PMC article.
G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer's Disease.
Bellver-Sanchis A, Geng Q, Navarro G, Ávila-López PA, Companys-Alemany J, Marsal-García L, Larramona-Arcas R, Miró L, Perez-Bosque A, Ortuño-Sahagún D, Banerjee DR, Choudhary BS, Soriano FX, Poulard C, Pallàs M, Du HN, Griñán-Ferré C. Bellver-Sanchis A, et al. Among authors: poulard c. Aging Dis. 2024 Feb 1;15(1):311-337. doi: 10.14336/AD.2023.0424-2. Aging Dis. 2024. PMID: 37307824 Free PMC article.
A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance.
Alegre-Martí A, Jiménez-Panizo A, Martínez-Tébar A, Poulard C, Peralta-Moreno MN, Abella M, Antón R, Chiñas M, Eckhard U, Piulats JM, Rojas AM, Fernández-Recio J, Rubio-Martínez J, Le Romancer M, Aytes Á, Fuentes-Prior P, Estébanez-Perpiñá E. Alegre-Martí A, et al. Among authors: poulard c. Sci Adv. 2023 Mar 17;9(11):eade2175. doi: 10.1126/sciadv.ade2175. Epub 2023 Mar 15. Sci Adv. 2023. PMID: 36921044 Free PMC article.
37 results